Cargando…

Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy

Objective. We aimed to demonstrate safety and efficacy of intravenous (IV) low molecular weight iron dextran (LMWID) during treatment of anemic stage 3 and 4 chronic kidney disease (CKD) patients. Methods. Efficacy data was obtained by retrospective chart review of 150 consecutively enrolled patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yessayan, Lenar, Sandhu, Ankur, Besarab, Anatole, Yessayan, Alexy, Frinak, Stan, Zasuwa, Gerard, Yee, Jerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614118/ https://www.ncbi.nlm.nih.gov/pubmed/23573422 http://dx.doi.org/10.1155/2013/703038

Ejemplares similares

Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study
por: Yessayan, Lenar, et al.
Publicado: (2014)

Innovations in CKRT: individualized therapy with fewer complications
por: Szamosfalvi, Balazs, et al.
Publicado: (2020)

Effect of hyperchloremia on acute kidney injury in critically ill septic patients: a retrospective cohort study
por: Yessayan, Lenar, et al.
Publicado: (2017)

Managing anemia in patients with chronic heart failure: what do we know?
por: Sandhu, Ankur, et al.
Publicado: (2010)

Remote Monitoring of Sustained Low-Efficiency Dialysis (SLED) Machines in Intensive Care Unit
por: Zasuwa, Gerard A., et al.
Publicado: (2022)

Detection of Hemodialysis Venous Needle Dislodgment Using Venous Access Pressure Measurements: A Simulation Study
por: Frinak, Stanley, et al.
Publicado: (2023)

Development and validation of a risk score to prioritize patients for evaluation of access stenosis
por: Astor, Brad C., et al.
Publicado: (2021)

Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients
por: Neyra, Javier A., et al.
Publicado: (2018)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Diagnostic value of end tidal capnography in patients with hyperglycemia in the emergency department
por: Bou Chebl, Ralphe, et al.
Publicado: (2016)

Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
por: Yessayan, Lenar T., et al.
Publicado: (2022)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis
por: Ali, Hatem, et al.
Publicado: (2020)

Safety Summary of the Selective Cytopheretic Device: A Review of Safety Data Across Multiple Clinical Trials in ICU Patients With Acute Kidney Injury and Multiple Organ Failure
por: Humes, H. David, et al.
Publicado: (2023)

Use of extracorporeal immunomodulation in a toddler with hemophagocytic lymphohistiocytosis and multisystem organ failure
por: Goldstein, Stuart L., et al.
Publicado: (2022)

Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
por: Yessayan, Lenar, et al.
Publicado: (2021)

Safety and Efficacy of Intravenous Iron Sucrose versus Low Molecular Weight Iron Dextran for Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
por: Samsudin, Sarah, et al.
Publicado: (2020)

Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human
por: Humes, H. David, et al.
Publicado: (2023)

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
por: Hussain, Iftikhar, et al.
Publicado: (2013)

Anemia management: development of a rapidaccess anemia and intravenous iron service
por: Radia, Deepti, et al.
Publicado: (2013)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA)
por: Neiser, Susann, et al.
Publicado: (2016)

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015)

Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria
por: Waziri, Bala, et al.
Publicado: (2016)

On the relevance of outpatient intravenous iron therapy for anemia management
por: Muñoz, Manuel
Publicado: (2011)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015)

Is there any role of intravenous iron for the treatment of anemia in cancer?
por: Gemici, Cengiz, et al.
Publicado: (2016)

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
por: Auerbach, Michael, et al.
Publicado: (2021)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
por: Besarab, Anatole, et al.
Publicado: (2015)

Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron
por: Silverberg, Donald S, et al.
Publicado: (2014)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)

Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
por: Das, Samarendra N., et al.
Publicado: (2020)

Prevalence of Iron Deficiency Anemia Indicated for Intravenous Iron Treatment in the Korean Population
por: Choi, Rihwa, et al.
Publicado: (2023)

Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
por: Gosavi, Rohit, et al.
Publicado: (2023)

Surveillance and Monitoring of Dialysis Access
por: Kumbar, Lalathaksha, et al.
Publicado: (2011)

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study
por: Louzada, Martha L., et al.
Publicado: (2016)

Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation
por: Lofruthe, Niklas, et al.
Publicado: (2016)

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece
por: Fragoulakis, Vassilis, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g133o9r6qgq8emb9813l0dgqmk